Poor functional status based on the New York Heart Association classification exposes the coronary patient to an elevated risk of ischemic stroke

American Heart Journal

Volumn 155, Issue 3, 2008, Pages 515-520

  Koren Morag, Nira ^a   Goldbourt, Uri ^a,b   Tanne, David ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BEZAFIBRATE;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; FEMALE; FUNCTIONAL STATUS; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK;

AGED; ANTILIPEMIC AGENTS; BEZAFIBRATE; BRAIN ISCHEMIA; CONFIDENCE INTERVALS; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SOCIETIES, MEDICAL; TIME FACTORS;

EID: 39149088641     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.10.032     Document Type: Article

References (29)

1. Bakhai A. The burden of coronary, cerebrovascular and peripheral arterial disease. Pharmacoeconomics 22 (2004) 11-18
2. Tanne D., Shotan A., Goldbourt U., et al. Severity of angina pectoris and risk of ischemic stroke. Stroke 33 (2002) 245-250
3. Loh E., Sutton M.S., Wun C.C., et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 336 (1997) 251-257
4. The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis. 9th ed. (1994), Little, Brown, Boston (MA) 253-256
5. AHA Science Advisory. Assessment of functional capacity in clinical and research applications. Circulation 102 (2000) 1591-2597
6. Goldbourt U., Behar S., Reicher-Reiss H., et al. Rationale and design of a secondary prevention trial of increasing serum HDL cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease. Am J Cardiol 71 (1993) 909-915
7. SPSS ver 13.0 for winXP. Software: 2005.
8. Gorkin L., Norvell N.K., Rosen R.C., et al. Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy. Am J Cardiol 71 (1993) 1069-1073
9. Ganiats T.G., Browner D.K., and Dittrich H.C. Comparison of quality of well-being scale and NYHA functional status classification in patients with atrial fibrillation. Am Heart J 131 5 Pt 1 (1998) 819-824
10. Scrutinio D., Lagioia R., Ricci A., et al. Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction. The role of the New York Heart Association classification, cardiopulmonary exercise testing, two-dimensional echocardiography and Holter monitoring. Eur Heart J 15 (1994) 1089-1095
11. van den Broek S.A., van Veldhuisen D.J., de Graeff P.A., et al. Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 70 (1992) 359-363
12. Bennett J.A., Riegel B., Bittner V., et al. Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart Lung 31 (2002) 262-270
13. Brittner V., Weiner D.H., Yusuf S., et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction, SOLVD Investigators. JAMA 270 (1993) 1702-1707
14. Rostagno C., Galanti G., Comeglio M., et al. Comparison of different methods of functional evaluation in patients with chronic heart failure. Eur J Heart Fail 2 (2000) 273-280
15. Rostagno C., Olivo G., Comeglio M., et al. Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation. Eur J Heart Fail 5 (2003) 247-252
16. Ahmed A. A propensity matched study of New York Heart Association class and natural history end points in heart failure. Am J Cardiol 99 (2007) 549-553
17. Abdulla J., Pogue J., Abildstrom S.Z., et al. Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction-a meta-analysis. Eur J Heart Fail 8 (2006) 90-96
18. O'Meara E., Solomon S., McMurray J., et al. Effect of candesartan on New York Heart Association functional class. Results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) programme. Eur Heart J 25 (2004) 1920-1926
19. Cotter G., Cannon C.P., McCabe C.H., et al. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis in Myocardial Infarction (OPUS-TIMI) 16 study. Am Heart J 145 (2003) 622-627
20. Koren-Morag N., Tanne D., and Goldbourt U. White blood cell count and the incidence of ischemic stroke in coronary heart disease patients. Am J Med 118 (2005) 1004-1009
21. Kallikazaros I.E., Tsioufis C.P., Stefanadis C.I., et al. Closed relation between carotid and ascending aortic atherosclerosis in cardiac patients. Circulation 102 (2000) 263-268
22. Demopoulos L.A., Tunick P.A., Bernstein N.E., et al. Protruding atheromas of the aortic arch in symptomatic patients with carotid artery disease. Am Heart J 129 (1995) 40-44
23. Kannel W.B., Wolf P.A., and Verter J. Manifestations of coronary disease predisposing to stroke. The Framingham study. JAMA 250 (1983) 2942-2946
24. Lampe F.C., Whincup P.H., Wannamethee S.G., et al. The natural history of prevalent ischaemic heart disease in middle-aged men. Eur Heart J 21 (2000) 1052-1062
25. Mooe T., Olofsson B.O., Stegmayr B., et al. Ischemic stroke. Impact of a recent myocardial infarction. Stroke 30 (1999) 997-1001
26. Tanne D., Goldbourt U., Zion M., et al. Frequency and prognosis of stroke/TIA among 4808 survivors of acute myocardial infarction. The SPRINT Study Group. Stroke 24 (1993) 1490-1495
27. Martin R., and Bogousslavsky J. Mechanism of late stroke after myocardial infarct: the Lausanne Stroke Registry. J Neurol Neurosurg Psychiatry 56 (1993) 760-764
28. Hays A.G., Sacco R.L., Rundek T., et al. Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population. Stroke 37 (2006) 1715-1719
29. Lip G.Y., and Gibbs C.R. Does heart failure confer a hypercoagulable state? Virchow's triad revisited. J Am Coll Cardiol 33 (1999) 1424-1426